A detailed history of Prosperity Consulting Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 75,533 shares of PFE stock, worth $1.98 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
75,533
Previous 57,280 31.87%
Holding current value
$1.98 Million
Previous $1.6 Million 36.39%
% of portfolio
0.17%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $505,608 - $572,961
18,253 Added 31.87%
75,533 $2.19 Million
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $217,665 - $255,063
-8,617 Reduced 13.08%
57,280 $1.6 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $503,068 - $577,683
19,431 Added 41.82%
65,897 $1.83 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $55,839 - $72,529
-2,137 Reduced 4.4%
46,466 $1.34 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $227,518 - $265,945
7,090 Added 17.08%
48,603 $1.61 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $66,316 - $76,726
-1,836 Reduced 4.24%
41,513 $1.52 Million
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $88,469 - $115,174
-2,246 Reduced 4.93%
43,349 $1.77 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $8,684 - $11,336
208 Added 0.46%
45,595 $2.34 Million
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $396,509 - $484,038
9,061 Added 24.94%
45,387 $1.99 Million
Q2 2022

Jul 25, 2022

SELL
$46.53 - $55.17 $8,421 - $9,985
-181 Reduced 0.5%
36,326 $1.91 Million
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $2,104 - $2,607
-46 Reduced 0.13%
36,507 $1.89 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $1.51 Million - $2.24 Million
36,553 New
36,553 $1.97 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.